| Santhosh Ambika, MD | |
|
5423 Reno Corporate Dr., Reno, NV 89511-2250 | |
| (775) 329-0873 | |
| (775) 329-1026 |
| Full Name | Santhosh Ambika |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 23 Years |
| Location | 5423 Reno Corporate Dr., Reno, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174747323 | NPI | - | NPPES |
| V113098 | Other | NV | INDIVIDUAL PTAN |
| VAA101126 | Other | VA | MEDICARE PTAN |
| C05754 | Other | VA | MEDICARE GROUP PTAN |
| 1417027608 | Other | VA | GROUP NPI |
| VWCHGC | Other | NV | GROUP PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZH0000X | Pathology - Hematology | 16308 (Nevada) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 16308 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Renown Regional Medical Center | Reno, NV | Hospital |
| Renown South Meadows Medical Center | Reno, NV | Hospital |
| Banner Lassen Medical Center | Susanville, CA | Hospital |
| Humboldt General Hospital | Winnemucca, NV | Hospital |
| Northern Nevada Medical Center | Sparks, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| John A Shields, Md Steven A Schiff, Md A Professional Corporation | 6507757572 | 17 |
News Archive
Pennsylvania Senate Republicans on Tuesday unveiled a health care proposal that would enhance care provided at community health centers and create a high-risk pool for state residents who are unable to obtain health coverage elsewhere, the AP/Philadelphia Inquirer reports (Raffaele, AP/Philadelphia Inquirer, 6/10).
Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Yale University, a premier university with a long tradition of both basic and clinically directed biomedical research, announce an exclusive worldwide license agreement concerning the development and commercialization of Debio 1036, a first-in-class inhibitor for autoimmune and inflammatory diseases.
Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells (CSCs), today announced that it holds the license, from the University of Pittsburgh ("Pitt"), for the exclusive worldwide rights to a clinically active oncology vaccine directed to multiple defined targets on tumor bulk and CSCs.
Industry leader in family-based treatment for almost twenty years, New Haven Residential Treatment Center announced the opening of its new residential home and new school for teen girls on its Saratoga Springs Campus, located 30 minutes south of Salt Lake City.
Osteologix, Inc. (OTCBB:OLGX) today announced that the Japan Patent Office (JPO) has issued a Decision to Grant a Patent for Application Number 2006-504379: "Treating Cartilage/Bone Conditions with Water-Soluble Strontium Salts". The patent claims cover the treatment of osteoporosis and related bone conditions using NB S101 (strontium malonate), the Company's lead osteoporosis drug candidate.
› Verified 1 days ago
| Entity Name | John A Shields, Md Steven A Schiff, Md A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861514580 PECOS PAC ID: 6507757572 Enrollment ID: O20040322000445 |
News Archive
Pennsylvania Senate Republicans on Tuesday unveiled a health care proposal that would enhance care provided at community health centers and create a high-risk pool for state residents who are unable to obtain health coverage elsewhere, the AP/Philadelphia Inquirer reports (Raffaele, AP/Philadelphia Inquirer, 6/10).
Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Yale University, a premier university with a long tradition of both basic and clinically directed biomedical research, announce an exclusive worldwide license agreement concerning the development and commercialization of Debio 1036, a first-in-class inhibitor for autoimmune and inflammatory diseases.
Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells (CSCs), today announced that it holds the license, from the University of Pittsburgh ("Pitt"), for the exclusive worldwide rights to a clinically active oncology vaccine directed to multiple defined targets on tumor bulk and CSCs.
Industry leader in family-based treatment for almost twenty years, New Haven Residential Treatment Center announced the opening of its new residential home and new school for teen girls on its Saratoga Springs Campus, located 30 minutes south of Salt Lake City.
Osteologix, Inc. (OTCBB:OLGX) today announced that the Japan Patent Office (JPO) has issued a Decision to Grant a Patent for Application Number 2006-504379: "Treating Cartilage/Bone Conditions with Water-Soluble Strontium Salts". The patent claims cover the treatment of osteoporosis and related bone conditions using NB S101 (strontium malonate), the Company's lead osteoporosis drug candidate.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Santhosh Ambika, MD 5423 Reno Corporate Dr, Reno, NV 89511-2250 Ph: (775) 329-0873 | Santhosh Ambika, MD 5423 Reno Corporate Dr., Reno, NV 89511-2250 Ph: (775) 329-0873 |
News Archive
Pennsylvania Senate Republicans on Tuesday unveiled a health care proposal that would enhance care provided at community health centers and create a high-risk pool for state residents who are unable to obtain health coverage elsewhere, the AP/Philadelphia Inquirer reports (Raffaele, AP/Philadelphia Inquirer, 6/10).
Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Yale University, a premier university with a long tradition of both basic and clinically directed biomedical research, announce an exclusive worldwide license agreement concerning the development and commercialization of Debio 1036, a first-in-class inhibitor for autoimmune and inflammatory diseases.
Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells (CSCs), today announced that it holds the license, from the University of Pittsburgh ("Pitt"), for the exclusive worldwide rights to a clinically active oncology vaccine directed to multiple defined targets on tumor bulk and CSCs.
Industry leader in family-based treatment for almost twenty years, New Haven Residential Treatment Center announced the opening of its new residential home and new school for teen girls on its Saratoga Springs Campus, located 30 minutes south of Salt Lake City.
Osteologix, Inc. (OTCBB:OLGX) today announced that the Japan Patent Office (JPO) has issued a Decision to Grant a Patent for Application Number 2006-504379: "Treating Cartilage/Bone Conditions with Water-Soluble Strontium Salts". The patent claims cover the treatment of osteoporosis and related bone conditions using NB S101 (strontium malonate), the Company's lead osteoporosis drug candidate.
› Verified 1 days ago
Dr. Richard Bruce Rosen, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 781 Mill St, Reno, NV 89502 Phone: 775-398-1980 Fax: 775-398-1981 | |
Rahul Navin Mediwala, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1500 E 2nd St, Suite 201, Reno, NV 89502 Phone: 775-982-3355 Fax: 775-982-3356 | |
Dr. Raymond Hill Scott Iii, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 330 Crampton St, Reno, NV 89502 Phone: 775-336-3700 Fax: 775-336-3701 | |
Dr. Bruce William Denney, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1155 Mill St Ms W14, Reno, NV 89502 Phone: 775-982-7878 Fax: 775-982-4196 | |
Dr. Elmer Epres Alegre, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1715 Kuenzli St, Reno, NV 89502 Phone: 775-329-5162 Fax: 775-334-4356 | |
Dr. Devang Mahesh Desai, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 645 N Arlington Ave Ste 555, Reno, NV 89503 Phone: 775-770-7622 Fax: 775-770-3683 | |
Dr. Louis Christopher Tripoli, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1510 Meadow Wood Ln, Prominence Health, Reno, NV 89502 Phone: 775-770-9242 Fax: 928-832-2864 |